We are live on
!
Find out more
VC
Vivo Capital Portfolio holdings
AUM
$1.2B
1-Year Est. Return
911.44%
This Fund
S&P 500
1 Year Est. Return
+911.44%
AUM
$1.2B
AUM Growth
-$344M
(-22%)
Holding
55
Top Buys
| 1 | +$34M | |
| 2 | +$20M | |
| 3 | +$15.1M | |
| 4 |
Sensei Biotherapeutics
SNSE
|
+$14.4M |
| 5 |
Corvus Pharmaceuticals
CRVS
|
+$9.12M |
Top Sells
| 1 | +$211M | |
| 2 | +$165M | |
| 3 | +$73M | |
| 4 |
AVDL
Avadel Pharmaceuticals
AVDL
|
+$57.8M |
| 5 |
ZBIO
Zenas BioPharma
ZBIO
|
+$31M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
enGene Therapeutics Warrants
ENGNW
$2.76M
| – | – |
-285,046
|
|
||
52
Palisade Bio
PALI
$297M
| – | – |
-2,293,578
|
|
||
|
SLN
53
Silence Therapeutics
SLN
$316M
| – | – |
-1,105,454
|
|
||
54
Verastem
VSTM
$360M
| – | – |
-1,106,524
|
|
||
|
ZBIO
55
Zenas BioPharma
ZBIO
$1.25B
| – | – |
-853,495
|
|